Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001482981-25-000143

CFO & Head of Corp. Dev. sold 52,000 shares at an average $21.62 ($1,124,335)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ridloff Elena CFO & Head of Corp. Dev. 2025-08-19 Sale 10b5-1 −34,500 $21.08 $727,260 89,032 D: show line 1 in the form
Ridloff Elena CFO & Head of Corp. Dev. 2025-08-20 Sale 10b5-1 −17,500 $22.69 $397,075 71,532 D: show line 2 in the form
Open-market sales · 52,000 sh · avg $21.62 · $1,124,335
Loading xslF345X05/edgardoc.xml…